BIO-TECHNE Corp — Director's Dealing 2025

Jan 29, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-01-27

Reporting Person: Kelderman Kim (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-27	Common Stock	M	13392	$37.70	Acquired	52396	Direct
2025-01-27	Common Stock	S	11731	$77.1915	Disposed	40665	Direct
2025-01-27	Common Stock	S	1661	$77.9530	Disposed	39004	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-27	Stock Option (Right to Buy)	$37.70	M	13392	Disposed	2025-05-01	Common Stock (13392)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$44.33	2025-08-08	Common Stock (84308)	84308	Direct
Stock Option (Right to Buy)	$47.60	2026-08-07	Common Stock (109536)	109536	Direct
Stock Option (Right to Buy)	$66.97	2027-08-05	Common Stock (115724)	115724	Direct
Stock Option (Right to Buy)	$120.46	2028-08-06	Common Stock (25944)	25944	Direct
Performance Restricted Stock Units	$		Common Stock (6984)	6984	Direct
Performance Stock Options (Right to Buy)	$94.52	2029-08-15	Common Stock (21704)	21704	Direct
Stock Options (Right to Buy)	$94.52	2029-08-15	Common Stock (28940)	28940	Direct
Performance Restricted Stock Units	$		Common Stock (8873)	8873	Direct
Performance Stock Options (Right to Buy)	$84.61	2030-08-15	Common Stock (23881)	23881	Direct
Stock Options (Right to Buy)	$84.61	2030-08-15	Common Stock (29391)	29391	Direct
Stock Options (Right to Buy)	$52.83	2030-11-01	Common Stock (38252)	38252	Direct
Performance Restricted Stock Units	$		Common Stock (9423)	9423	Direct
Performance Stock Options (Right to Buy)	$68.54	2031-02-01	Common Stock (25945)	25945	Direct
Stock Options (Right to Buy)	$68.54	2031-02-01	Common Stock (51890)	51890	Direct
Performance Restricted Stock Units	$		Common Stock (51261)	51261	Direct
Restricted Stock Units	$		Common Stock (25630)	25630	Direct
Stock Options (Right to Buy)	$74.91	2034-08-15	Common Stock (69061)	69061	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.67 to $77.66 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.69 to $78.08 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: Fully exercisable.

F4: Options to purchase 6,484 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 6,488 shares vest on each of 8/6/2024 and 8/6/2025.

F5: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F6: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F7: Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.

F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F9: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.

F10: Options to purchase 9,563 shares vest on each of 11/1/2024, 11/1/2025, 11/1/2026 and 11/1/2027.

F11: Options to purchase 12,973 shares vest on each of 2/1/2025 and 2/1/2027, and options to purchase 12,972 shares vest on each of 2/1/2026 and 2/1/2028.

F12: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F13: 8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027.

F14: Options to purchase 17,265 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 17,266 shares vest on 8/15/2028.